Amphastar Pharmaceuticals AMPH Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $170.94M+0.4% | $170.18M-21.3% | $216.27M+15.2% | $187.69M+2.7% | $182.78M+20.6% | ||
| $121.01M+7.4% | $112.64M+87.9% | $59.94M+36.0% | $44.06M-18.6% | $54.1M-22.8% | ||
| $147.85M+3.0% | $143.56M-2.2% | $146.81M+10.4% | $132.98M-8.1% | $144.64M+6.1% | ||
| $170.19M-3.8% | $176.89M-4.9% | $185.93M-3.0% | $191.73M+3.4% | $185.48M+20.6% | ||
| $633.68M-0.4% | $636.02M-0.5% | $639.47M+10.1% | $580.83M-1.2% | $587.96M+10.1% | ||
| $307.23M-1.1% | $310.57M+0.6% | $308.69M-0.5% | $310.24M+0.9% | $307.6M+3.4% | ||
| $559.62M-1.1% | $565.97M-1.1% | $572.24M-1.1% | $578.5M-1.0% | $584.53M-1.0% | ||
| $1.65B+1.2% | $1.63B-2.2% | $1.67B+3.2% | $1.62B-0.7% | $1.63B+3.1% | ||
| $152.69M+2.9% | $148.35M-22.3% | $190.84M+14.6% | $166.55M-5.3% | $175.94M+12.0% | ||
| $1.67M+1.8% | $1.64M+77.8% | $923K-0.4% | $927K+314% | $224K-4.3% | ||
| $164.48M+4.0% | $158.16M-22.9% | $205.23M+16.3% | $176.41M-11.4% | $199.05M+14.6% | ||
| $609.8M+0.2% | $608.75M0.0% | $608.58M+0.1% | $607.73M+0.6% | $603.86M+0.4% | ||
| $874.77M+4.1% | $840.49M-5.5% | $889.48M+3.7% | $857.85M-2.0% | $874.99M+3.5% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $673.3M+1.0% | $666.88M+3.8% | $642.45M+2.8% | $625.1M+5.2% | $594.07M+4.4% | ||
| $1.65B+1.2% | $1.63B-2.2% | $1.67B+3.2% | $1.62B-0.7% | $1.63B+3.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
- How much cash does Amphastar Pharmaceuticals have?
- Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
- Can Amphastar Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.85 — current assets exceed current liabilities.
- Where does Amphastar Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
